FDA inspects pharmaceutical manufacturing
facilities worldwide using scientifically and cGMP trained individuals, whose
job it's to evaluate whether the company is following the cGMP regulations.
FDA also relies upon reports of potentially defective drug products from the
public and the industry. FDA will often use these reports to identify sites for
which an inspection or investigation is needed. Most companies that are
inspected are found to be fully compliant with the cGMP regulations.
No comments:
Post a Comment